Homocysteine and MTHFR C677T polymorphism in children and adolescents with psychotic and mood disorders

References

• Bolander-Gouaille C, Bottiglieri T. Homocysteine. Related vitamins and neuropsychiatric disorders, 2nd edition. Berlin: Springer-Verlag; 2007. p. 15–29.
   Google Scholar
• Bottiglieri T, Laundy M, Crellin R, Toone BK, Carney MW, Reynolds EH. Homocysteine, folate, methylation, and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry 2000;69:228–32.
   PubMed Web of Science ®Google Scholar
• Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG. MTHFR Studies Collaboration Group: MTHFR 677C→T polymorphism and risk of coronary heart disease: A meta-analysis. JAMA 2002;288:2023–31.
   PubMed Web of Science ®Google Scholar
• Coppen A, Bolander-Gouaille C. Treatment of depression: Time to consider folic acid and vitamin B12. J Psychopharmacol 2005;19:59–65.
   PubMed Web of Science ®Google Scholar
• Muntjewerff JW, Kahn RS, Blom HJ, den Heijer M. Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: A meta-analysis. Mol Psychiatry 2006;11:143–9.
   PubMed Web of Science ®Google Scholar
• Kempisty B, Bober A, Luczak M, Czerski P, Szczepankiewicz A. Hauser J, et al. Distribution of 1298A > C polymorphism of methylenetetrahydrofolate reductase gene in patients with bipolar disorder and schizophrenia. Eur J Psychiat 2007;22:39–43.
   Google Scholar
• Murray CJ, Lopez AD. The global burden of disease: A comprehensive assessment of mortality and disability from disease, injuries and risk factors in 1990. Boston, MA: Harvard School of Publics Health; 1996.
   Google Scholar
• Brown AS, Bottiglieri T, Schaefer C, Quesenberry C, Liu L, Bresnahan M, et al. Elevated prenatal homocysteine levels as a risk factor for schizophrenia. Arch Gen Psychiatry 2007;64:31–9.
   PubMed Web of Science ®Google Scholar
• Makhro AV, Bulygina ER, Boldyrev AA. Effects of homocysteine and homocysteine acid on cerebellar granule cells. J Neurochem 2007;2:127–32.
   Google Scholar
• Lipton SA, Kim WK, Choi YB, Kumar S, Dèmilia DM., Rayudu PV, et al. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-d-aspartate receptor. Proc Natl Acad Sci USA 1997;94:5923–8.
   PubMed Web of Science ®Google Scholar
• Friedman A, Kaufer D, Shemer J, Hendler I, Soreq H, Tur-Kaspa I. Pyridostigmine brain penetration under stress enhances neuronal excitability and induces immediate transcriptional response. Natur Med 1996;2:1382–5.
   PubMed Web of Science ®Google Scholar
• Levine J, Sela BA, Osher Y, Belmaker RH. High homocysteine serum levels in young male schizophrenia bipolar patients and in an animal model. Prog Neuro-psychopharmand Biol Psych 2005;29:1181–91.
   PubMed Web of Science ®Google Scholar
• Ninger LJ. Homocysteine as a Risk Factor for Disease. Life Extension Magazine [serial online], 2006 October [cited November 2, 2011]. Available from: http://www.lef.org/magazine/mag2006/oct2006_report_risk_01.htm
   Google Scholar
• International Statistical Classification of Diseases and Related Health Problems 10th Revision. [cited January 7, 2012]. Available from: http://apps.who.int/classifications/icd10/browse/2010/en#/F20
   Google Scholar
• Ausubel I., Frederick M. In: Current protocols in molecular biology, 1st edition. New York: Oxford University Press; 1987.
   Google Scholar
• Woerner MF, Manuzza S, Kane JM. Anchoring the BPRS: An aid to improved reliability. Psychopharmacol Bull, 1988;24:112–17.
   PubMed Web of Science ®Google Scholar
• Hamilton, M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56–62.
   PubMed Web of Science ®Google Scholar
• Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50–5.
   PubMed Web of Science ®Google Scholar
• Murray RM, Lewis SW. Is schizophrenia a neurodevelopmental disorder?. Br Med J 1987;295:681–2.
   PubMed Web of Science ®Google Scholar
• Levine J, Sela BA, Osher Y, Belmaker RH. Elevated homocysteine levels in euthymic bipolar disorders patients showing functional deterioration. Bipolar Disord 2004;6:82–6.
   PubMedGoogle Scholar
• Marinho C, Alho I, Arduıno D, Falcao LM, Brás-Nogueira J, Bicho M. GST M1/T1 and MTHFR polymorphisms as risk factors for hypertension. Biochem Biophys Res Commun 2007;344–50.
   Google Scholar
• Sadock BJ, Sadock VA. Synopsis of psychiatry, 10th edition. Philadelphia, PA: Lippincott Williams & Wilkins; 2007, p.467–526.
   Google Scholar
• Grieco AJ. Homocystinuria: Pathogenetic mechanisms. Am J Med Sci 1977;273:120–132.
   PubMedGoogle Scholar
• Ковалев BB. Психиатрия детского возраста (Psychiatry of childhood). Москва: Медицина; 1979, p. 330–376.
   Google Scholar
• Тиганов АС. Руководство по психиатрии (Manual of psychiatry). Том 1. Москва: Медицина; 1999, p. 636–667.
   Google Scholar
• Cantoni GL. S—Anenysylmethionine: A new intermediate formed enzymatically from 1-methionine and adenosine triphosphate. J Biol Chem 1953;204:403–16.
   PubMed Web of Science ®Google Scholar
• Rozen R. Molecular genetics of methylenetetrahydrofolate reductase deficiency. J Inherit Metab Dis 1996;19:589–94.
   PubMedGoogle Scholar
• Molloy KJ, Daly S, Mills JL, Kirke PN, Whitehead AS, Ramsbottom D, et al. Thermolabile variant of 5,10-methylenetetrahydrofolate reductase association with low red-cell folates: Implications for folate intake recommendations. Lancet 1997;349:1591–3.
   PubMed Web of Science ®Google Scholar
• Reif A, Pfuhlmann B, Lesch KP. Homocysteinemia as well as methylenetetrahydrofolate reductase polymorphism are associated with affective psychoses. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:1162–8.
   PubMed Web of Science ®Google Scholar
• Nevo GA, Meged S, Sela BA. Homocysteine levels in adolescent schizophrenia patients. Eur Neuropsychopharmacol 2006;16:588–91.
   PubMedGoogle Scholar